InsiderTrades

Form 4 for CCAP Crescent Capital BDC, Inc.

Accepted 2022-01-10 00:00:00 ET · period of report 2022-01-06 · accession 0000947871-22-000026 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2022-01-10 2022-01-06+ CCAP FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 10% S - Sale $18.02 -74.8K 3.21M -2% -$1.35M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-01-10 S D 20,238 $18.02 3,145,902 I See footnote — — (F2) The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F4) This transaction was executed in multiple trades at prices ranging from $18.00 to $18.08. The shares sold include 14,621 shares sold by Allied World and 5,617 shares sold by Brit. (F5) These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.
2 Common Common Stock 2022-01-07 S D 40,914 $18.03 3,166,140 I See footnote — — (F2) The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F3) This transaction was executed in multiple trades at prices ranging from $18.00 to $18.15. The shares sold include 29,559 shares sold by Allied World and 11,355 shares sold by Brit. (F5) These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.
3 Common Common Stock 2022-01-06 S D 13,659 $18.01 3,207,054 I See footnote — — (F2) The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) This transaction was executed in multiple trades at prices ranging from $18.00 to $18.06. The shares sold include 9,868 shares sold by Allied World Assurance Company, Ltd., GmbH ("Allied World") and 3,791 shares sold by Brit Reinsurance (Bermuda) Limited - FAL ("Brit"), which are both subsidiaries of Fairfax Financial Holdings Limited. (F5) These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.